<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40334">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02096523</url>
  </required_header>
  <id_info>
    <org_study_id>002714- HMO-CTIL</org_study_id>
    <nct_id>NCT02096523</nct_id>
  </id_info>
  <brief_title>Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder</brief_title>
  <official_title>Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hebrew University of Jerusalem</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to identify the platelet defect responsible for the bleeding in
      families from our inherited platelet disorders Israeli-Palestinian  registry. The
      investigators plan to characterize platelet proteome expression after removing high
      abundance proteins. The investigators will compare the proteome of sick and healthy members
      of families with inherited platelet disorders, and identify and validate structural
      proteins, signaling cascades and biomarkers for detection and diagnosis of unknown platelet
      disorders. The investigators expect to discover new key findings that allow better
      understanding of human platelet function and allow better diagnosis and treatment of
      patients with inherited platelet function disorders.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Levels of detectable platelet proteins</measure>
    <time_frame>2014-2015 (1 year)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Characterize platelet proteome expression profile</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in protein expression from sick and healthy platelets</measure>
    <time_frame>2015-2019 (4 years)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Analysis of platelet proteome of sick and healthy members of families with inherited platelet disorders</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of proteins that inducate disease</measure>
    <time_frame>2017-2019 (2 years)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Identify and validate a panel of specific biomarkers candidates</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Inherited Platelet Disorders</condition>
  <arm_group>
    <arm_group_label>platelet disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with inherited platelet disorders</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy family members of patients with inherited platelet disorders</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood collection for platelet protein samples</intervention_name>
    <arm_group_label>platelet disease</arm_group_label>
    <arm_group_label>Healthy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of inherited platelet disorders in the family

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Galia Spectre, MD</last_name>
    <phone>00 972 2 6776737</phone>
    <email>galias@hadassah.org.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hadas Lemberg, PhD</last_name>
      <phone>972 2 6777572</phone>
      <email>lhadas@hadassah.org.il</email>
    </contact>
    <investigator>
      <last_name>Galia Spectre, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shoshana Ravel-Vilk, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 23, 2014</lastchanged_date>
  <firstreceived_date>March 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>inherited platelet disorders</keyword>
  <keyword>proteome</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Hemorrhagic Disorders</mesh_term>
    <mesh_term>Blood Platelet Disorders</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
